Analyst Price Targets — PAHC
Latest News for PAHC
Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) CEO Jack Bendheim sold 7,040 shares of Phibro Animal Health stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $54.64, for a total value of $384,665.60. Following the sale, the chief executive officer directly owned 117,000 shares in
Phibro Animal Health Corporation (NASDAQ: PAHC - Get Free Report) CEO Jack Bendheim sold 7,040 shares of the stock in a transaction dated Tuesday, April 14th. The shares were sold at an average price of $59.08, for a total transaction of $415,923.20. Following the completion of the transaction, the chief executive officer directly owned 31,080 shares
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck right now?
Phibro Animal Health, Deluxe, Remitly Global and BrightSpring Health Services, Inc. (BTSG) represent four compelling small-cap stocks.
PAHC stock surges 152% in a year, fueled by strong animal health demand, Zoetis MFA integration and growing vaccine momentum.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PAHC.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.